Saevar Berg Gudbergsson1, Sophie D Fosså, Alv A Dahl. 1. Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo: Faculty of Medicine, Montebello, 0310, Oslo, Norway. bergg@ulrik.uio.no
Abstract
GOALS OF WORK: The goal of this study is to explore the characteristics of tumor-free cancer survivors (CSs) who after their primary treatment were still working but made work changes due to cancer and compare them to survivors who did not. PATIENTS AND METHODS: The sample consisted of 431 CSs (219 females with breast cancer, 212 males with testicular (N = 150) or prostate cancer (N = 62)) diagnosed 2-6 years prior to the study. All CSs had good prognosis and had returned to work after primary treatment. All CSs filled in a mailed questionnaire covering demography, morbidity, life style, mental distress, fatigue, quality of life and job strain. RESULTS: Seventy-two CSs (17%) had made work changes due to cancer during the observation period, and 359 (83%) had not. Among CSs who made work changes, significantly more were females; they showed significantly poorer physical and mental work ability, worked fewer hours per week, reported more comorbidity, and had lower physical and mental quality of life and more neuroticism, compared to the nonchange group. Work changes were moderately correlated with current work ability. CONCLUSIONS: The majority of CSs did not report any work changes due to cancer during the 2-6-year observation period, which is an encouraging finding. A minority had done work changes, and this group consisted mainly of women and was also characterized by poorer physical and mental quality of life and poorer mental work ability due to cancer. The issue of work changes and work ability should be considered in the follow-up of cancer survivors.
GOALS OF WORK: The goal of this study is to explore the characteristics of tumor-free cancer survivors (CSs) who after their primary treatment were still working but made work changes due to cancer and compare them to survivors who did not. PATIENTS AND METHODS: The sample consisted of 431 CSs (219 females with breast cancer, 212 males with testicular (N = 150) or prostate cancer (N = 62)) diagnosed 2-6 years prior to the study. All CSs had good prognosis and had returned to work after primary treatment. All CSs filled in a mailed questionnaire covering demography, morbidity, life style, mental distress, fatigue, quality of life and job strain. RESULTS: Seventy-two CSs (17%) had made work changes due to cancer during the observation period, and 359 (83%) had not. Among CSs who made work changes, significantly more were females; they showed significantly poorer physical and mental work ability, worked fewer hours per week, reported more comorbidity, and had lower physical and mental quality of life and more neuroticism, compared to the nonchange group. Work changes were moderately correlated with current work ability. CONCLUSIONS: The majority of CSs did not report any work changes due to cancer during the 2-6-year observation period, which is an encouraging finding. A minority had done work changes, and this group consisted mainly of women and was also characterized by poorer physical and mental quality of life and poorer mental work ability due to cancer. The issue of work changes and work ability should be considered in the follow-up of cancer survivors.
Authors: J Winterling; E Johansson; A Wennman-Larsen; L-M Petersson; P Ljungman; K Alexanderson Journal: Bone Marrow Transplant Date: 2014-03-10 Impact factor: 5.483
Authors: Michael Feuerstein; Briana L Todd; Michal C Moskowitz; Gina L Bruns; Mallori R Stoler; Thomas Nassif; Xinhua Yu Journal: J Cancer Surviv Date: 2010-10-14 Impact factor: 4.442
Authors: Marc A Emerson; Bryce B Reeve; Melissa B Gilkey; Shekinah N C Elmore; Sandi Hayes; Cathy J Bradley; Melissa A Troester Journal: J Cancer Surviv Date: 2022-09-14 Impact factor: 4.062
Authors: Linda M Frazier; Virginia A Miller; Douglas V Horbelt; James E Delmore; Brigitte E Miller; Ellen P Averett Journal: Cancer Control Date: 2009-01 Impact factor: 3.302
Authors: Marieke van Leeuwen; Jacobien M Kieffer; Fabio Efficace; Sophie D Fosså; Michel Bolla; Laurence Collette; Marc Colombel; Ugo De Giorgi; Bernhard Holzner; Lonneke V van de Poll-Franse; Hendrik van Poppel; Jeff White; Ronald de Wit; Susanne Osanto; Neil K Aaronson Journal: Health Qual Life Outcomes Date: 2017-05-11 Impact factor: 3.186